Literature DB >> 26396235

Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis.

Jennifer Cheng1, Ryan T Dackor1, J Alyce Bradbury1, Hong Li1, Laura M DeGraff1, Lee K Hong1, Debra King1, Fred B Lih1, Artiom Gruzdev1, Matthew L Edin1, Gregory S Travlos1, Gordon P Flake1, Kenneth B Tomer1, Darryl C Zeldin2.   

Abstract

Cyclooxygenase (COX)-2 has been shown to be involved in regulating basal airway function, bacterial LPS-induced airway hyperresponsiveness (AHR) and lung inflammation, and bleomycin-induced lung fibrosis; however, the cellular source of COX-2 that underlies these effects is unknown. We generated mice with alveolar type II (ATII) cell-specific knockdown of COX-2 (AT2CC(-/-)), to examine the role of ATII cell-derived prostaglandins (PGs) in these processes. Specific knockdown of COX-2 was confirmed by real-time RT-PCR and Western blot analyses. LC/MS/MS analysis showed that ATII cells produced PGs. Basal airway responsiveness of AT2CC(-/-) mice was decreased compared to that of wild-type (WT) mice. LPS-induced hypothermic response, infiltration of inflammatory cells into the airway, and lung inflammation were enhanced in AT2CC(-/-) mice relative to WT controls; however, LPS-induced AHR and proinflammatory cytokine and chemokine expression were similar between the genotypes. After 21 d of bleomycin administration, AT2CC(-/-) mice behaved in a manner similar to WT mice. Thus, ATII cell-derived COX-2 plays an important role in regulating basal airway function and LPS-induced lung inflammation, but does not play a role in bleomycin-induced fibrosis. These findings provide insight into the cellular source of COX-2 related to these lung phenotypes. © FASEB.

Entities:  

Keywords:  airway hyperresponsiveness; bleomycin; lipopolysaccharide; prostaglandins

Mesh:

Substances:

Year:  2015        PMID: 26396235      PMCID: PMC4684524          DOI: 10.1096/fj.14-268458

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  36 in total

Review 1.  Cre/loxP recombination system and gene targeting.

Authors:  Ralf Kühn; Raul M Torres
Journal:  Methods Mol Biol       Date:  2002

2.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.

Authors:  S H Lee; E Soyoola; P Chanmugam; S Hart; W Sun; H Zhong; S Liou; D Simmons; D Hwang
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

Review 3.  Pulmonary fibrosis: thinking outside of the lung.

Authors:  Stavros Garantziotis; Mark P Steele; David A Schwartz
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 4.  Isolation and culture of alveolar type II cells.

Authors:  L G Dobbs
Journal:  Am J Physiol       Date:  1990-04

5.  Airway fibrosis in rats induced by vanadium pentoxide.

Authors:  J C Bonner; A B Rice; C R Moomaw; D L Morgan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

6.  Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production.

Authors:  Rebecca J Hodges; R Gisli Jenkins; Caroline P D Wheeler-Jones; Danielle M Copeman; Stephen E Bottoms; Geoffrey J Bellingan; Carmel B Nanthakumar; Geoffrey J Laurent; Stephen L Hart; Martyn L Foster; Robin J McAnulty
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors.

Authors:  A K Bauer; L D Dwyer-Nield; A M Malkinson
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

8.  Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis.

Authors:  James C Bonner; Annette B Rice; Jennifer L Ingram; Cindy R Moomaw; Abraham Nyska; Alyce Bradbury; Alisha R Sessoms; Patricia C Chulada; Daniel L Morgan; Darryl C Zeldin; Robert Langenbach
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death.

Authors:  Kuniaki Ejima; Matthew D Layne; Irvith M Carvajal; Patricia A Kritek; Rebecca M Baron; Yen-Hsu Chen; Jeffrey Vom Saal; Bruce D Levy; Shaw-Fang Yet; Mark A Perrella
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

10.  Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung.

Authors:  V L Goncalves de Moraes; B Boris Vargaftig; J Lefort; A Meager; M Chignard
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more
  11 in total

1.  Protective Role of Surfactant Protein-D Against Lung Injury and Oxidative Stress Induced by Nitrogen Mustard.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Jessica A Cervelli; Elena V Ebramova; Andrew J Gow; Michael Goedken; Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2018-11-01       Impact factor: 4.849

2.  World Trade Center (WTC) dust exposure in mice is associated with inflammation, oxidative stress and epigenetic changes in the lung.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Mingzhu Fang; Helmut Zarbl; Christopher Massa; Andrew J Gow; Jessica A Cervelli; Howard Kipen; Robert J Laumbach; Paul J Lioy; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2016-12-13       Impact factor: 3.362

3.  The PGI2 Analog Cicaprost Inhibits IL-33-Induced Th2 Responses, IL-2 Production, and CD25 Expression in Mouse CD4+ T Cells.

Authors:  Weisong Zhou; Jian Zhang; Shinji Toki; Kasia Goleniewska; Marc O Johnson; Melissa H Bloodworth; Dawn C Newcomb; R Stokes Peebles
Journal:  J Immunol       Date:  2018-08-20       Impact factor: 5.422

4.  Zinc and iron complexes of oleanolic acid, (OA) attenuate allergic airway inflammation in rats.

Authors:  Adnan Jehangir; Muhammad Shahzad; Khadija Shahid; Akbar Waheed; Farhana Ayub
Journal:  Inflammopharmacology       Date:  2019-05-08       Impact factor: 4.473

5.  Curcumin Attenuates Airway Inflammation and Airway Remolding by Inhibiting NF-κB Signaling and COX-2 in Cigarette Smoke-Induced COPD Mice.

Authors:  Jin Yuan; Renping Liu; Yaohui Ma; Zhaoqiang Zhang; Zehao Xie
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

6.  The Role of PGE2 in Alveolar Epithelial and Lung Microvascular Endothelial Crosstalk.

Authors:  Thomas Bärnthaler; Jovana Maric; Wolfgang Platzer; Viktoria Konya; Anna Theiler; Carina Hasenöhrl; Benjamin Gottschalk; Sandra Trautmann; Yannick Schreiber; Wolfgang F Graier; Rudolf Schicho; Gunther Marsche; Andrea Olschewski; Dominique Thomas; Rufina Schuligoi; Akos Heinemann
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

7.  Niacin ameliorates ulcerative colitis via prostaglandin D2-mediated D prostanoid receptor 1 activation.

Authors:  Juanjuan Li; Deping Kong; Qi Wang; Wei Wu; Yanping Tang; Tingting Bai; Liang Guo; Lumin Wei; Qianqian Zhang; Yu Yu; Yuting Qian; Shengkai Zuo; Guizhu Liu; Qian Liu; Sheng Wu; Yi Zang; Qian Zhu; Daile Jia; Yuanyang Wang; Weiyan Yao; Yong Ji; Huiyong Yin; Masataka Nakamura; Michael Lazarus; Richard M Breyer; Lifu Wang; Ying Yu
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

8.  Parecoxib reduced ventilation induced lung injury in acute respiratory distress syndrome.

Authors:  Fan-You Meng; Wei Gao; Ying-Nan Ju
Journal:  BMC Pharmacol Toxicol       Date:  2017-03-29       Impact factor: 2.483

9.  Network pharmacology-based strategy to investigate the active ingredients and molecular mechanisms of Scutellaria Barbata D. Don against radiation pneumonitis.

Authors:  Ping-Yi Sun; Ai-Shuai Wang; Zhen-Fei Zhang; Yan-Li Zhang; Xin Zheng
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

10.  Nuclear factor-kappa B influences early phase of compensatory lung growth after pneumonectomy in mice.

Authors:  Yusuke Takahashi; Noriyuki Matsutani; Hitoshi Dejima; Takashi Nakayama; Hirofumi Uehara; Masafumi Kawamura
Journal:  J Biomed Sci       Date:  2017-07-05       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.